Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kazia Therapeutics Limite...

    NASDAQ: KZIA · Real-Time Price · USD
    9.38
    0.33 (3.65%)
    At close: Jun 17, 2025, 10:32 AM

    Kazia Therapeutics Statistics

    Share Statistics

    Kazia Therapeutics has 967.05K shares outstanding. The number of shares has increased by 83.97% in one year.

    Shares Outstanding

    n/a
    		 967.05K

    Shares Change (YoY)

    n/a
    		 83.97%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.02%

    Shares Floating

    n/a
    		 685.55K

    Failed to Deliver (FTD) Shares

    n/a
    		 198

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 14.39K, so 0.26% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 14.39K

    Short % of Shares Out

    n/a
    		 0.26%

    Short % of Float

    n/a
    		 0.26%

    Short Ratio (days to cover)

    n/a
    		 1.23

    Valuation Ratios

    The PE ratio is -0.29 and the forward PE ratio is -0.78. Kazia Therapeutics's PEG ratio is -0.54.

    PE Ratio

    n/a
    		 -0.29

    Forward PE

    n/a
    		 -0.78

    PS Ratio

    n/a
    		 3.38

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 -0.78

    P/FCF Ratio

    n/a
    		 -0.82

    PEG Ratio

    n/a
    		 -0.54
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kazia Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.24, with a Debt / Equity ratio of -0.06.

    Current Ratio

    n/a
    		 0.24

    Quick Ratio

    n/a
    		 0.24

    Debt / Equity

    n/a
    		 -0.06

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.07

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $256,444.44

    Profits Per Employee

    n/a
    		 $-2,975,333.33

    Employee Count

    n/a
    		 9

    Asset Turnover

    n/a
    		 0.11

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -271K

    Effective Tax Rate

    n/a
    		 1%

    Stock Price Statistics

    The stock price has increased by -20% in the last 52 weeks. The beta is 2.48, so Kazia Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.48

    52-Week Price Change

    n/a
    		 -20%

    50-Day Moving Average

    n/a
    		 4.23

    200-Day Moving Average

    n/a
    		 12.38

    Relative Strength Index (RSI)

    n/a
    		 78.64

    Average Volume (20 Days)

    n/a
    		 837,175

    Income Statement

    In the last 12 months, Kazia Therapeutics had revenue of 2.31M and earned -26.78M in profits. Earnings per share was -55.85.

    Revenue

    n/a
    		 2.31M

    Gross Profit

    n/a
    		 2.31M

    Operating Income

    n/a
    		 n/a

    Net Income

    n/a
    		 -26.78M

    EBITDA

    n/a
    		 -26.77M

    EBIT

    n/a
    		 -28.64M

    Earnings Per Share (EPS)

    n/a
    		 -55.85
    Full Income Statement

    Balance Sheet

    The company has 1.66M in cash and 634K in debt, giving a net cash position of 1.02M.

    Cash & Cash Equivalents

    n/a
    		 1.66M

    Total Debt

    n/a
    		 634K

    Net Cash

    n/a
    		 1.02M

    Retained Earnings

    n/a
    		 -115.13M

    Total Assets

    n/a
    		 21.59M

    Working Capital

    n/a
    		 -19.65M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.58M and capital expenditures 0, giving a free cash flow of -9.58M.

    Operating Cash Flow

    n/a
    		 -9.58M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -9.58M

    FCF Per Share

    n/a
    		 -0.04
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 0% and -1160.23%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 -1171.97%

    Profit Margin

    n/a
    		 -1160.23%

    EBITDA Margin

    n/a
    		 -1159.71%

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 -415.12%

    Dividends & Yields

    KZIA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KZIA is $57.5, which is 525% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $57.5

    Price Target Difference

    n/a
    		 525%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 17, 2025. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Apr 17, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 -16.49

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist